• OPEN AN ACCOUNT
Indian Indices
Sensex
76,917.85 1,225.07
( 1.62%)
Global Indices
Nasdaq
52,165.19 373.88
(0.72%)
Dow Jones
7,596.72 -4.35
(-0.06%)
Hang Seng
63,112.86 -177.25
(-0.28%)
Nikkei 225
10,768.78 39.00
(0.36%)
Forex
USD-INR
94.93 -0.28
(-0.30%)
EUR-INR
105.90 -0.29
(-0.27%)
GBP-INR
127.09 0.08
(0.06%)
JPY-INR
0.60 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
524661
INE331C01025
0.785022
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
23.48
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Coal India subsidiary South Eastern Coalfields files DRHP for proposed primary listing
Nov 02,2026
Coal India announced that the draft red herring prospectus dated 01 November 2026 of South Eastern Coalfields (SECL), a wholly owned subsidiary of Coal India, was filed with SEBI, BSE and NSE.

The DRHP filing pertains to the proposed Initial Public Offering ('IPO') of SECL, comprising an Offer for Sale of up to 668,056,100 equity shares having a face value of Rs 2 each, held by Coal India.

The proposed IPO remains subject to receipt of applicable approvals, prevailing market conditions, and other relevant considerations.